Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Current Assets (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Current Assets for 7 consecutive years, with $196.4 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 45.77% to $196.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $196.4 million through Dec 2025, down 45.77% year-over-year, with the annual reading at $196.4 million for FY2025, 45.77% down from the prior year.
  • Current Assets for Q4 2025 was $196.4 million at Pliant Therapeutics, down from $245.6 million in the prior quarter.
  • The five-year high for Current Assets was $588.2 million in Q1 2023, with the low at $173.5 million in Q2 2022.
  • Average Current Assets over 5 years is $347.4 million, with a median of $325.8 million recorded in 2022.
  • The sharpest move saw Current Assets skyrocketed 226.0% in 2023, then plummeted 45.77% in 2025.
  • Over 5 years, Current Assets stood at $209.4 million in 2021, then skyrocketed by 62.49% to $340.3 million in 2022, then soared by 48.54% to $505.5 million in 2023, then decreased by 28.34% to $362.3 million in 2024, then tumbled by 45.77% to $196.4 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $196.4 million, $245.6 million, and $267.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.